Peposertib, a DNAPK inhibitor, enhances the antitumor efficacy of anthracyclines in triple-negative breast cancer models in vitro and in vivo

被引：1
|
作者：
Revia, Steffie
Sirrenberg, Christian
Schach, Antonia
Zimmermann, Astrid
Zenke, Frank T.
Albers, Joachim
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6215
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6215
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Targeting CDK7 enhances the antitumor efficacy of enzalutamide in androgen receptor-positive triple-negative breast cancer
    Xie, Xuemei
    Manai, Marwa
    Fuson, Jon A.
    Pearson, Troy
    Rampa, Dileep R.
    Tripathy, Debu
    Lee, Jangsoon
    Ueno, Naoto T.
    CANCER RESEARCH, 2023, 83 (05)
  • [32] Birinapant Enhances Gemcitabine's Antitumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway-Dependent Apoptosis
    Xie, Xuemei
    Lee, Jangsoon
    Liu, Huey
    Pearson, Troy
    Lu, Alexander Y.
    Tripathy, Debu
    Devi, Gayathri R.
    Bartholomeusz, Chandra
    Ueno, Naoto T.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (02) : 296 - 306
  • [33] In vivo efficacy of the PARG inhibitor Gallotannin against triple negative breast cancer
    Zhao, Tiejun
    Sun, Qiang
    Lovato, Amanda
    del Rincon, Sonia
    Witcher, Michael
    CANCER RESEARCH, 2013, 73 (08)
  • [34] Eribulin Enhances Interferon Production by STING Agonists in Models of Triple-Negative Breast Cancer
    Takahashi-Ruiz, Leila
    Fermaintt, Charles S.
    Chan, Peter Y.
    Liang, Hui
    Mooberry, Susan L.
    Risinger, April L.
    FASEB JOURNAL, 2022, 36
  • [35] Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
    Silver, Daniel P.
    Richardson, Andrea L.
    Eklund, Aron C.
    Wang, Zhigang C.
    Szallasi, Zoltan
    Li, Qiyuan
    Juul, Nicolai
    Leong, Chee-Onn
    Calogrias, Diana
    Buraimoh, Ayodele
    Fatima, Aquila
    Gelman, Rebecca S.
    Ryan, Paula D.
    Tung, Nadine M.
    De Nicolo, Arcangela
    Ganesan, Shridar
    Miron, Alexander
    Colin, Christian
    Sgroi, Dennis C.
    Ellisen, Leif W.
    Winer, Eric P.
    Garber, Judy E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : 1145 - 1153
  • [36] The efficacy of betulinic acid in triple-negative breast cancer
    Weber, Daniel
    Zhang, Mixia
    Zhuang, Pengwei
    Zhang, Yanjun
    Wheat, Janelle
    Currie, Geoffrey
    Al-Eisawi, Zaynab
    SAGE OPEN MEDICINE, 2014, 2
  • [37] Non-steroid anti-inflammatory treatment enhances the efficacy of modulated electro hyperthermia on triple-negative breast cancer and melanoma cancer models in vivo
    Giunashvili, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S202 - S202
  • [38] In Vitro and In Vivo Anti-Cancer Activity of Lasiokaurin in a Triple-Negative Breast Cancer Model
    Lin, Jinrong
    Qu, Zhao
    Pu, Huanhuan
    Shen, Li-Sha
    Yi, Xianguo
    Lin, Yu-Shan
    Gong, Rui-Hong
    Chen, Guo-Qing
    Chen, Sibao
    MOLECULES, 2023, 28 (23):
  • [39] Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer
    Zuo, Shuting
    Wang, Jing
    An, Xianquan
    Wang, Zhenyu
    Zheng, Xiao
    Zhang, Yan
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [40] In Vitro and In Vivo Effects of Docetaxel and Dasatinib in Triple-Negative Breast Cancer: A Research Study
    Passos, Ioannis D.
    Papadimitriou, Dimochristos
    Katsouda, Areti
    Papavasileiou, Georgios E.
    Galatas, Apostolos
    Tzitzis, Panagiotis
    Mpakosi, Alexandra
    Mironidou-Tzouveleki, Maria
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
12345